Dr. Reddy's Laboratories

Hyderabad, India Founded: 1984 • Age: 42 yrs
Innovative medicines are developed and manufactured globally by the company.
Request Access

About Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is a company based in Hyderabad (India) founded in 1984.. The company has 27,810 employees as of March 31, 2024. Dr. Reddy's Laboratories has completed 9 acquisitions, including Betapharm, Cidmus and Habitrol. Dr. Reddy's Laboratories offers products and services including Generic Medicines and Active Pharmaceutical Ingredients.

  • Headquarter Hyderabad, India
  • Employees 27810 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Dr. Reddy's Laboratories Ltd.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
    $3.81 B (USD)
    16.61
    as on Mar 31, 2025
  • Net Profit
    $661.8 M (USD)
    1.54
    as on Mar 31, 2025
  • EBITDA
    $1.01 B (USD)
    9.97
    as on Mar 31, 2025
  • Latest Funding Round
    $3.45 M (USD), Post-IPO

    Feb 26, 2025

  • Investors
  • Employee Count
    27810

    as on Mar 31, 2024

  • Investments & Acquisitions
    Betapharm

    & 8 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Dr. Reddy's Laboratories

Dr. Reddy's Laboratories is a publicly listed company on the NSE with ticker symbol DRREDDY in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: DRREDDY . Sector: Health technology · India

Products & Services of Dr. Reddy's Laboratories

Dr. Reddy's Laboratories offers a comprehensive portfolio of products and services, including Generic Medicines and Active Pharmaceutical Ingredients. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Generic medicines are produced for treating common health conditions

Active pharmaceutical ingredients are supplied for use in drug formulations

People of Dr. Reddy's Laboratories
Headcount 10000+
Employee Profiles 656
Board Members and Advisors 8
Employee Profiles
People
Srinivas Cherukuri
Manager
People
Abigail Amato Blunda
Senior Director, People & Organization Partner - NA
People
Sayanta Bhattacharyya
Territory Manager
People
Jodi Evenson
Director, Sales - West

Unlock access to complete

Board Members and Advisors
people
Satish Reddy
Chairman
people
Shikha Sharma
Director
people
Leo Puri
Director
people
K P Krishnan
Director

Unlock access to complete

Funding Insights of Dr. Reddy's Laboratories

  • Total Funding
  • Total Rounds 3
  • Last Round Post-IPO — $3.4M
  • First Round

    (01 Oct 2016)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2025 Amount Post-IPO - Dr. Reddy's Laboratories Valuation

investors

Jun, 2022 Amount Post-IPO - Dr. Reddy's Laboratories Valuation

investors

Oct, 2016 Amount Grant - Dr. Reddy's Laboratories Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Dr. Reddy's Laboratories

Dr. Reddy's Laboratories has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Digit Insurance and Gates Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Charitable foundation investments on poverty reduction and healthcare
Founded Year Domain Location
General and life insurance products are provided across multiple categories.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Dr. Reddy's Laboratories

Dr. Reddy's Laboratories has strategically engaged in corporate development activities, having acquired 9 companies. Notable acquisitions include Betapharm, Cidmus and Habitrol. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Provider of business consulting services
2023
Probiotic supplements for menopause symptoms are developed.
2019
Cannabinoid-based drugs are developed and branded by Nimbus Health.
2018
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Dr. Reddys Laboratories

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Dr. Reddy's Laboratories Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Dr. Reddy's Laboratories

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Dr. Reddy's Laboratories

Frequently Asked Questions about Dr. Reddy's Laboratories

When was Dr. Reddy's Laboratories founded?

Dr. Reddy's Laboratories was founded in 1984 and raised its 1st funding round 32 years after it was founded.

Where is Dr. Reddy's Laboratories located?

Dr. Reddy's Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Who is the current CEO of Dr. Reddy's Laboratories?

Erez Israeli is the current CEO of Dr. Reddy's Laboratories.

How many employees does Dr. Reddy's Laboratories have?

As of Mar 31, 2024, the latest employee count at Dr. Reddy's Laboratories is 27,810.

What is the annual revenue of Dr. Reddy's Laboratories?

Annual revenue of Dr. Reddy's Laboratories is $3.81B as on Mar 31, 2025.

What does Dr. Reddy's Laboratories do?

Dr. Reddys Laboratories was founded in 1984 in Hyderabad, India, and operates as a multinational pharmaceutical entity. Active pharmaceutical ingredients, generics, branded generics, biosimilars, and over-the-counter products are produced across therapeutic areas such as gastrointestinal, cardiovascular, oncology, anti-infectives, pediatrics, and dermatology. Operations span global markets with a focus on drug development and manufacturing.

What products or services does Dr. Reddy's Laboratories offer?

Dr. Reddy's Laboratories offers Generic Medicines and Active Pharmaceutical Ingredients.

Is Dr. Reddy's Laboratories publicly traded?

Yes, Dr. Reddy's Laboratories is publicly traded on NSE under the ticker symbol DRREDDY.

How many acquisitions has Dr. Reddy's Laboratories made?

Dr. Reddy's Laboratories has made 9 acquisitions, including Betapharm, Cidmus, and Habitrol.

Who are Dr. Reddy's Laboratories's investors?

Dr. Reddy's Laboratories has 2 investors. Key investors include Digit Insurance, and Gates Foundation.

What is Dr. Reddy's Laboratories's ticker symbol?

The ticker symbol of Dr. Reddy's Laboratories is DRREDDY on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available